---
figid: PMC11012862__ijms-25-04098-g003
pmcid: PMC11012862
image_filename: ijms-25-04098-g003.jpg
figure_link: /pmc/articles/PMC11012862/figure/ijms-25-04098-f003/
number: Figure 3
figure_title: ''
caption: 'Biosynthetic pathway of GSLs: MSGb5, monosialosyl globopentaosylceramide;
  DSGb5, disialosyl globopentaosylceramide; GM3, monosialodihexosylganglioside; GM2,
  monosialotrihexosylganglioside; GM1, monosialotetrahexosylganglioside; DUPAN-2,
  Duke pancreatic monoclonal antigen type 2; GD1a, ganglioside disialic acid 1a; DSLc4,
  α(2,3)/α(2,6) disialyl lactotetraosylceramide; GalNAcDSLc4, N-acetylgalactosaminyl
  disialyl lactotetraosyl ceramide; CA19-9, carbohydrate antigen 19-9. The symbols
  are notated in the same way as in .'
article_title: Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids
  in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell
  Carcinoma.
citation: Masamitsu Maekawa, et al. Int J Mol Sci. 2024 Apr;25(7):4098.
year: '2024'

doi: 10.3390/ijms25074098
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- glycosphingolipids
- liquid chromatography/tandem mass spectrometry (LC–MS/MS)
- renal cell carcinoma
- disialosyl globopentaosylceramide (DSGb5)
- targeted lipidomics

---
